Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis.
作者信息
Moslehi Javid J, Salem Joe-Elie, Sosman Jeffrey A, Lebrun-Vignes Bénédicte, Johnson Douglas B
机构信息
Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA; Division of Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA; Cardio-Oncology Program, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA; Cardio-Oncology Program, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA; AP-HP, Pitié-Salpêtrière Hospital, Department of Pharmacology, CIC-1421, Pharmacovigilance Unit, INSERM, UMR ICAN 1166, Sorbonne Universités, UPMC Univ Paris 06, Faculty of Medicine, Institute of Cardiometabolism and Nutrition (ICAN), Paris, France.
出版信息
Lancet. 2018 Mar 10;391(10124):933. doi: 10.1016/S0140-6736(18)30533-6.
Abstract
摘要
相似文献
1
Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis.免疫检查点抑制剂相关致死性心肌炎报告增加。
Lancet. 2018 Mar 10;391(10124):933. doi: 10.1016/S0140-6736(18)30533-6.
2
Recurrent Myocarditis Induced by Immune-Checkpoint Inhibitor Treatment Is Accompanied by Persistent Inflammatory Markers Despite Immunosuppressive Treatment.免疫检查点抑制剂治疗诱发的复发性心肌炎，尽管进行了免疫抑制治疗，但仍伴有持续性炎症标志物。
JCO Precis Oncol. 2021 Mar 11;5. doi: 10.1200/PO.20.00370. eCollection 2021 Mar.
3
Immune checkpoint inhibitors-related myocarditis in patients with cancer: an analysis of international spontaneous reporting systems.癌症患者免疫检查点抑制剂相关心肌炎：国际自发报告系统分析。
BMC Cancer. 2021 Jan 7;21(1):38. doi: 10.1186/s12885-020-07741-0.
4
A retrospective study of immune checkpoint inhibitor-associated myocarditis in a single center in China.中国单中心免疫检查点抑制剂相关性心肌炎的回顾性研究。
Chin Clin Oncol. 2020 Apr;9(2):16. doi: 10.21037/cco.2020.03.08. Epub 2020 Apr 7.
5
Fatal Case of Immune-Related Myocarditis and Myositis Due to Treatment with Immune Checkpoint and Tyrosine Kinase Inhibitors.免疫检查点抑制剂和酪氨酸激酶抑制剂治疗导致的免疫相关性心肌炎和肌炎致死病例
Acta Med Port. 2024 Dec 2;37(12):865-868. doi: 10.20344/amp.21306. Epub 2024 Oct 14.
6
Association between myocarditis and other immune-related adverse events secondary to immune checkpoint inhibitor use.免疫检查点抑制剂使用继发的心肌炎与其他免疫相关不良事件之间的关联。
Int J Cancer. 2020 Sep 15;147(6):1753-1754. doi: 10.1002/ijc.32960. Epub 2020 May 6.
7
Progressed Atrioventricular Block in Immune Checkpoint Inhibitor Induced Myocarditis: A Case Report.免疫检查点抑制剂诱发心肌炎进展为房室传导阻滞：一例报告
Pacing Clin Electrophysiol. 2025 Apr;48(4):414-417. doi: 10.1111/pace.15155. Epub 2025 Feb 6.
8
Immune checkpoint inhibitor-associated myocarditis: manifestations and mechanisms.免疫检查点抑制剂相关心肌炎：表现与机制。
J Clin Invest. 2021 Mar 1;131(5). doi: 10.1172/JCI145186.
9
An Emergent Form of Cardiotoxicity: Acute Myocarditis Induced by Immune Checkpoint Inhibitors.一种新兴的心脏毒性：免疫检查点抑制剂引起的急性心肌炎。
Biomolecules. 2021 May 22;11(6):785. doi: 10.3390/biom11060785.
10
Major Adverse Cardiovascular Events and the Timing and Dose of Corticosteroids in Immune Checkpoint Inhibitor-Associated Myocarditis.免疫检查点抑制剂相关心肌炎中的主要不良心血管事件以及皮质类固醇的使用时机和剂量
Circulation. 2020 Jun 16;141(24):2031-2034. doi: 10.1161/CIRCULATIONAHA.119.044703. Epub 2020 Jun 15.
引用本文的文献
1
Real-Life Management of Elevated Troponin Level in Patients Treated with Immune Checkpoint Inhibitors.免疫检查点抑制剂治疗患者肌钙蛋白水平升高的实际管理
CJC Open. 2025 Feb 13;7(8):1075-1082. doi: 10.1016/j.cjco.2025.02.005. eCollection 2025 Aug.
2
Using plasma cell-free mRNA to profile immune response and myocardial damage in immune checkpoint inhibitor-induced myocarditis.利用浆细胞游离mRNA分析免疫检查点抑制剂诱导的心肌炎中的免疫反应和心肌损伤。
J Clin Invest. 2025 Aug 15;135(16). doi: 10.1172/JCI188817.
3
Case With Refractory Myasthenia Gravis Caused by Pembrolizumab.帕博利珠单抗所致难治性重症肌无力病例
J Community Hosp Intern Med Perspect. 2025 May 5;15(3):59-62. doi: 10.55729/2000-9666.1486. eCollection 2025.
4
Prognostic Value of Biomarkers in Cancer Patients Treated With Immune Checkpoint Inhibitor Therapy.生物标志物在接受免疫检查点抑制剂治疗的癌症患者中的预后价值。
JACC Adv. 2025 Jul 31;4(9):102022. doi: 10.1016/j.jacadv.2025.102022.
5
Cardiovascular Toxicity Associated With Immune Checkpoint Inhibitors: Interpreting the Discrepancy Between Clinical Trials and Real-World Data.免疫检查点抑制剂相关的心血管毒性：解读临床试验与真实世界数据之间的差异
Cureus. 2025 Jun 30;17(6):e87049. doi: 10.7759/cureus.87049. eCollection 2025 Jun.
6
Immunotherapy-Induced Cardiotoxicity: A Narrative Review of Real-World Case Reports, Recent Information and Clinical Evidence.免疫疗法诱发的心脏毒性：真实世界病例报告、最新信息及临床证据的叙述性综述
Cardiovasc Toxicol. 2025 Jul 13. doi: 10.1007/s12012-025-10038-y.
7
Cardiovascular adverse effects of immunotherapy in cancer: insights and implications.癌症免疫治疗的心血管不良反应：见解与影响
Front Oncol. 2025 Jun 18;15:1601808. doi: 10.3389/fonc.2025.1601808. eCollection 2025.
8
Cardiotoxicity in cancer immunotherapy: a systematic review and global meta-analysis.癌症免疫治疗中的心脏毒性：一项系统评价和全球荟萃分析。
J Transl Med. 2025 Jul 1;23(1):718. doi: 10.1186/s12967-025-06768-w.
9
The predictive value of serial troponin measurements in patients treated with immune checkpoint inhibitors.免疫检查点抑制剂治疗患者中肌钙蛋白系列检测的预测价值。
Oncologist. 2025 Jun 4;30(6). doi: 10.1093/oncolo/oyaf147.
10
Immune-Related Fulminant Myocarditis Revealed Using Myocardial Histopathology at Autopsy in the Treatment of Advanced Renal Cell Carcinoma: A Case Report.晚期肾细胞癌治疗中尸检心肌组织病理学揭示的免疫相关性暴发性心肌炎：一例报告
Case Rep Oncol. 2025 May 7;18(1):738-743. doi: 10.1159/000546288. eCollection 2025 Jan-Dec.
本文引用的文献
1
Clinical Features, Management, and Outcomes of Immune Checkpoint Inhibitor-Related Cardiotoxicity.免疫检查点抑制剂相关心脏毒性的临床特征、管理及结局
Circulation. 2017 Nov 21;136(21):2085-2087. doi: 10.1161/CIRCULATIONAHA.117.030571.
2
Fulminant Myocarditis with Combination Immune Checkpoint Blockade.暴发性心肌炎合并免疫检查点阻断治疗
N Engl J Med. 2016 Nov 3;375(18):1749-1755. doi: 10.1056/NEJMoa1609214.
3
Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy.与 CTLA4 和 PD1 阻断免疫疗法相关的心脏毒性。
J Immunother Cancer. 2016 Aug 16;4:50. doi: 10.1186/s40425-016-0152-y. eCollection 2016.
4
PD-1 Blockers.PD-1 抑制剂。
Cell. 2015 Aug 27;162(5):937. doi: 10.1016/j.cell.2015.07.045.
Zotero 插件